Athira Pharma: Fosgonimeton May Outperform Lecanemab In Alzheimer’s
koto_feja Thesis I have covered Athira Pharma (NASDAQ:ATHA) before on June 22, 2022, the day of its press release which had the stock sell off from above $8 to about $2.65. In that article, I […]
